(29 days)
The Catapult Guide Sheath is indicated to be used for introduction of interventional and diagnostic devices into the peripheral (and coronary) vasculature.
The Catapult Guide Sheath consists of a coil reinforced introducer sheath with hemostasis valve and side port, as well as a dilator with a tapered tip and luer lock at the proximal end. The main introducer sheath tubing is connected at the proximal end to a hemostasis valve with side port tubing that is connected to a plastic color coded 3-way stopcock valve. The side port is used for flushing the introducer sheath. The introducer sheath is introduced into the vascular system with the aid of the dilator. The hemostasis valve at the proximal end of the introducer sheath conforms and seals around guide wires and catheters to reduce blood leakage from the introducer sheath. A radiopaque marker helps identify the distal end of the introducer sheath. The introducer sheath has a lubricious hydrophilic coating on the outer surface up to 20cm on the distal portion.
The System consists of the following components:
- A One Introducer Sheath) with hemostasis valve
- A One dilator or
- A Two dilators for 15 cm version
The shaft and hemostasis valve are pre-assembled and packaged together with a dilator. Each shaft and each dilator are placed in a separate protection tube, the protection tubes are fixated onto a packaging pad. Products are sealed inside a medical grade Tyvek pouch on which a product label is placed. Devices are packaged in labeled packers containing five units and one Instruction for Use (IFU) booklet.
The Catapult Guide Sheath is a sterile, disposable device. It is a prescription medical device that is used only in healthcare facilities or hospitals. The device is suitable for placement in patients for up to 24 hours.
Devices are sterilized using ethylene oxide. Maximum levels of remaining tested sterilant residuals meet requirement limits EO < 4mg/24h and ECH < 9mg/24h; while achieving Sterility Assurance Level SAL 10-6.
The provided document is a 510(k) summary for the Catapult Guide Sheath, a medical device. It describes the device, its intended use, comparison to a predicate device, and performance data. However, the document does not contain any information about an AI/ML-based device.
Therefore, I cannot provide an answer to your request regarding acceptance criteria and a study that proves an AI/ML device meets them, as the provided text pertains to a traditional medical device (Catheter Introducer).
If you can provide a document that describes the acceptance criteria and study for an AI/ML medical device, I would be happy to assist you.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
July 29, 2022
Contract Medical International s.r.o. Jan Kubicek Senior Regulatory Specialist Vazni 848 Hradec Kralove. 50011 Czech Republic
Re: K221914
Trade/Device Name: Catapult Guide Sheath Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB, DRE Dated: June 27, 2022 Received: June 30, 2022
Dear Jan Kubicek:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
{1}------------------------------------------------
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Finn Donaldson Team Lead DHT2C: Division of Coronary and Peripheral Intervention Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K221914
Device Name Catapult Guide Sheath
Indications for Use (Describe)
The Catapult Guide Sheath is indicated to be used for introduction of interventional and diagnostic devices into the peripheral (and coronary) vasculature.
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(k) SUMMARY
Submitter 1.1
Submitter: Contract Medical GmbH Lauensteiner Strasse 37 01277 Dresden Germany Contact Person: Juliana Vaz Nuernberger, Position: Global Head of Regulatory Affairs +49 351 210 747-19 Phone: Email: juliana.nuernberger@heraeus.com Date Summary Prepared: 28th July 2022
1.2 Device
| Device Trade Name: | Catapult Guide Sheath |
|---|---|
| Device Common Name: | Introducer Sheath |
| Classification Name: | Introducer Catheter, andDilator, Vessel, For Percutaneous Catheterization |
| Device Class: | II |
| Product Code: | DYB, and DRE |
1.3 Predicate Device
Predicate device: DuraSheath Introducer Sheath System (K181463)
Reference device: R2P Destination Slender Guiding Sheath (K193125)
1.4 Device Description
The Catapult Guide Sheath consists of a coil reinforced introducer sheath with hemostasis valve and side port, as well as a dilator with a tapered tip and luer lock at the proximal end. The main introducer sheath tubing is connected at the proximal end to a hemostasis valve with side port tubing that is connected to a plastic color coded 3-way stopcock valve. The side port is used for flushing the introducer sheath. The introducer sheath is introduced into the vascular system with the aid of the dilator. The hemostasis valve at the proximal end of the introducer sheath conforms and seals around guide wires and catheters to reduce blood leakage from the introducer sheath. A radiopaque marker helps identify the distal end of the introducer sheath. The introducer sheath has a lubricious hydrophilic coating on the outer surface up to 20cm on the distal portion.
The System consists of the following components:
- A One Introducer Sheath) with hemostasis valve
- A One dilator or
- A Two dilators for 15 cm version
{4}------------------------------------------------
The shaft and hemostasis valve are pre-assembled and packaged together with a dilator. Each shaft and each dilator are placed in a separate protection tube, the protection tubes are fixated onto a packaging pad. Products are sealed inside a medical grade Tyvek pouch on which a product label is placed. Devices are packaged in labeled packers containing five units and one Instruction for Use (IFU) booklet.
The Catapult Guide Sheath is a sterile, disposable device. It is a prescription medical device that is used only in healthcare facilities or hospitals. The device is suitable for placement in patients for up to 24 hours.
Devices are sterilized using ethylene oxide. Maximum levels of remaining tested sterilant residuals meet requirement limits EO < 4mg/24h and ECH < 9mg/24h; while achieving Sterility Assurance Level SAL 10-6.
Physical Description 1.5
The Catapult Guide Sheath exists in 4 French, 6 French, 7 French and 8 French sizes, each with effective lengths of 15 cm, 45 cm, 60 cm, or 90 cm.
Selected product versions are manufactured in one or more of the following shapes - Left Internal Mammary Artery (LIMA), Hockey Stick (HS), Multi-Purpose (MP) and Renal Double Curve (RDC). The shape of sheaths is formed by heating of distal part of straight product versions.
| ID(French) | Length | Coating | Straight | Multipurpose(MP) | LeftInternalMammaryArtery(LIMA) | RenalDoubleCurve(RDC) | HockeyStick(HS) |
|---|---|---|---|---|---|---|---|
| 4F | 15cm | 5cm | x | ||||
| 4F | 45cm | 10cm | x | ||||
| 4F | 60cm | 10cm | x | ||||
| 4F | 90cm | 20cm | x | ||||
| 5F | 15cm | 5cm | x | ||||
| 5F | 45cm | 10cm | x | x | x | x | |
| 5F | 60cm | 10cm | x | ||||
| 5F | 90cm | 20cm | x | ||||
| 6F | 15cm | 5cm | x | ||||
| 6F | 45cm | 10cm | x | x | x | x | x |
| 6F | 60cm | 10cm | x | ||||
| 6F | 90cm | 20cm | x | x | x | x | |
| 7F | 15cm | 5cm | x | ||||
| 7F | 45cm | 10cm | x | x | x | x | x |
| 7F | 60cm | 10cm | x |
Device Models 1.6
{5}------------------------------------------------
| 7F | 90cm | 20cm | X | X | X | |
|---|---|---|---|---|---|---|
| 8F | 15cm | 5cm | X | |||
| 8F | 45cm | 10cm | X | |||
| 8F | 60cm | 10cm | X | |||
| 8F | 90cm | 20cm | X |
Table 1 - Catapult Guide Sheath Device Models
Indications for Use 1.7
The Catapult Guide Sheath is indicated to be used for introduction of interventional and diagnostic devices into the peripheral (and coronary) vasculature.
Device Comparison 1.8
The new versions of the Catapult Guide Sheath are a manually operated, sterile, single patient use sheath system made predominantly of thermoplastic polymers. The sheath is reinforced with a stainless-steel coil in order to provide kink resistance when passed through tortuous paths. Regarding the design, device features, method of sterilization, and mode of operation, the new versions of Catapult Guide Sheath does not differ from the predicate device.
Materials used for manufacture of the new Catapult Guide Sheath are the same or very similar as those contained in the predicate device.
| Characteristics | Subject DeviceCatapult Guide Sheath | PredicateDuraSheath Introducer Sheath System |
|---|---|---|
| Trade name | Catapult Guide Sheath | DuraSheath Introducer Sheath System |
| Indications for use | The Catapult Guide Sheath is indicated to beused for introduction of interventional anddiagnostic devices into the peripheral (andcoronary) vasculature.* These Indications for Use for the subjectdevice are a subset of those cleared for thePredicate | The DuraSheath Introducer Sheath Systemis indicated to be used for introduction ofinterventional and diagnostic devices intothe peripheral (and coronary) vasculature.The device is also intended to be usedwithin a pediatric population. |
| Principle of operation | Manual operation where the sheath isinserted and removed over dilator andguidewire | Same |
| French sizes | 4F to 8F | Same |
| Effective lengths | 15, 45, 60 and 90cm | Same |
| Shaft distal shapeconfiguration | Straight and curved | Straight |
| Hemostasis valve | Polycarbonate (Valve body and cap) | Same |
| Characteristics | Subject DeviceCatapult Guide Sheath | PredicateDuraSheath Introducer Sheath System |
| material | Silicone (Valve disc +lubricant) | Same |
| Hemostasis valve design | Removable hemostasis valve (disk valve)with side port | Same |
| Side port for flushing | Side port tubing with a color coded 3-waystopcock | Same |
| Stopcock material | Polycarbonate (body)Acetal (handle)Polyurethane (extension line) | Same |
| Shaft outer layer (cover)material | PebaxColorant | Polyurethane (some models)PebaxColorant |
| Shaft reinforcementmaterial | Stainless steel coil | Same |
| Shaft inner layer (liner)material | PTFE inner layer | Same |
| Shaft proximal connection | Luer connector | Same |
| Shaft / Dilator luer hub | Luer hub (Pebax), colour coded | Same |
| Lubricious coating | Hydrophilic coating | Hydrophobic coating |
| Shaft radiopaque marker | Platinum iridium marker at the distal end | Same |
| Dilator material | Pebax with Barium sulphate (Dilator body)Pebax (Dilator hub) | Same |
| Dilator design | Tapered tip on dilator.Color coded hub.Snap fit between dilator and valve cap.Shape - Straight | Same |
| Guidewire included | No | Same |
| Radiation safety | Fluoroscopy allowed. | Same |
| Sterile package | Pouch | Same |
| Sterilization method /Sterilization AssuranceLevel (SAL) | Ethylene oxide cycleSAL 10-6 | Same |
| Shelf Life | 3 years | Same |
| Compatibility with otherdevices | Guidewires up to 0.018 (15cm version only),0,035 for 4F-6F and 0.038 7F-8F inches andinstruments up to inner diameter forintroducer sheath. | Same |
| French Size/Guidewirecompatibility marking | French size of the devices is differentiatedby color-coding of sheath and dilator Luerhub. Maximum guide wire size is referencedin labelling or in case of 15cm versionadditionally on dilator hub. | Same |
{6}------------------------------------------------
Table 2 - Device Comparison
{7}------------------------------------------------
Performance Data 1.9
Performance data demonstrate that the new Catapult Guide Sheath is substantially equivalent to the predicate. The following performance data from non-clinical tests support the substantial equivalence determination:
- . Mechanical testing, including tests required under relevant international standards, and usability test performed to verify and validate the design.
- . Biocompatibility Risk Assessment (BRA) and performed biocompatibility device testing to demonstrate biocompatibility.
- . Sterilization information to confirm sterility of the device upon exposure to the selected sterilization EO cycle.
- Accelerated aging testing to confirm product performance at the end of the shelf life.
The list of tests performed in support of determination of substantial equivalence is provided in Table 3.
| No. | Verification / ValidationActivity | Test Type | Results | Applicable Standard(s)(Recognized Consensus # ifapplicable] |
|---|---|---|---|---|
| 1 | Visual and DimensionalEvaluation | Visual | Pass | Internal requirement |
| 2 | Sheath/dilator fit test | Mechanical/Visual | Pass | Internal requirement |
| 3 | Sheath pull out test | Mechanical/Visual | Pass | ISO 10555-1:2013 (6-408)IEC 62366-1:2020 (5-129)Internal requirement |
| 4 | Coating integrity | Mechanical/Visual | Pass | Internal requirementCompared to reference device:R2P Destination Slender GuidingSheath (K193125) |
| 5 | Sheath Liquid LeakageLiquid leakage throughhemostasis valve | Mechanical/Visual | Pass | ISO 11070:2014 (N/A)ISO 10555-1:2013 (6-408) |
| 6 | Coating integrity - Particleevaluation test | Mechanical/Visual | Pass | AAMI TIR42 (3-172)ISO 8536-4 (6-447)USP <788> (N/A for medicaldevices)Compared to reference device:R2P Destination Slender GuidingSheath (K193125) |
| No. | Verification / ValidationActivity | Test Type | Results | Applicable Standard(s)(Recognized Consensus # ifapplicable] |
| 7 | Sheath kink resistance test | Mechanical | Pass | EN 13868:2002 (N/A)Internal requirement |
| 8 | Sheath force at break testSheath creep to break testDilator hub bond strength | Mechanical | Pass | ISO 10555-1:2013 (6-408)ISO 11070:2014 (N/A)Internal requirement |
| 9 | Sheath Stiffness test | Mechanical | Pass | Internal requirement |
| 10 | Usability evaluationSimulated use test | Usability Study | Pass | IEC 62366-1:2020 (5-129)Internal requirement |
| 11 | Accelerated Age Study | Mechanical/ ExternalLaboratory | Pass | ASTM F1980-16 (14-497)Various per performed tests |
| 12 | Biocompatibility testingCytotoxicityHemolysisPartial ThromboplastinTime (PTT)Complement activationBiological Risk Assessment | External LaboratoryDocumentedassessment | Pass | ISO 10993-1:2018 (2-258)ISO 10993-4:2017 (2-248)ISO 10993-5:2009 (2-245)ISO 10993-10:2010 (2-174)ISO 10993-11:2017 (2-255)ISO 10993-12:2012 (2-191)ISO 14971:2019 (5-125)FDA Guidance Use of InternationalStandard ISO 10993-1 |
| 13 | Sterilization adoption | Documentedassessment /External laboratorytesting | Pass | ISO 10993-7:2008 (14-408)ISO 11737-1:2018 (14-514)ISO 11135:2014 (14-529)ISO 10993-1:2018 (2-258)AAMI TIR28:2009 (N/A) |
| 14 | Visibility of the sheathunder X-ray | Documentedassessment | Leveragedfrom predicate | ASTM F 640-20 (8-556)ISO 11070:2014 (N/A) |
| 15 | Packaging integrityassessment | Documentedassessment | Leveragedfrom predicate | EN 868-5:2019ASTM F88/F88M-15(14-482)ISO 11607-1 Second edition 2019-02 (14-530) |
{8}------------------------------------------------
Table 3 - Testing overview
{9}------------------------------------------------
1.10 Conclusions
Based on the intended use, technological characteristics, and performance data provided, the Catapult Guide Sheath is considered appropriate for the intended use. The technological and material differences between the subject and predicate devices do not raise new questions of safety or effectiveness. The subject Catapult Guide Sheath device is considered to be substantially equivalent to the predicate DuraSheath Introducer Sheath System (K181463).
§ 870.1340 Catheter introducer.
(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).